Suppr超能文献

多形核细胞释放的可溶性肿瘤坏死因子受体及乳腺癌患者治疗前后的血清水平。

Soluble TNF receptors release by polymorphonuclear cells and the serum levels in breast cancer patients before and after treatment.

作者信息

Jabłońska E, Kiluk M, Markiewicz W

机构信息

Department of Immunopathology, Medical Academy, Białystok, Poland.

出版信息

Neoplasma. 1998;45(1):17-20.

PMID:9604996
Abstract

Soluble cytokine receptors by binding to circulating cytokines play an important role in the regulation of immune response of the host. Measurement of their release may be helpful in the evaluation of cytokine-mediated reactions in patients with cancer disease. Soluble tumor necrosis factor receptors (sTNF-Rs) in the culture supernatants of PMNs and in the sera obtained from patients with breast cancer were determined. The examinations were carried out before and after treatment involving surgery and chemotherapy. The highest concentrations of sTNFRp55 and sTNFRp75 were observed in the culture supernatants of PMNs from patients before any treatment, the lower concentrations of them were found in the supernatants of PMNs after treatment. Sera from breast cancer patients presented increased levels of sTNFRp55 and sTNFRp75. Surgery treatment resulted in higher concentrations of sTNFRp55 and sTNFRp75. Decreased sTNF-Rs serum levels were obtained in patients after adjuvant chemotherapy. Different ability of PMNs to the release of TNF-regulatory proteins-sTNFRs appears to confirm PMNs participation in TNF-mediated reactions of the host during malignant process via sTNF-Rs release.

摘要

可溶性细胞因子受体通过与循环中的细胞因子结合,在宿主免疫反应调节中发挥重要作用。检测其释放情况可能有助于评估癌症患者细胞因子介导的反应。测定了中性粒细胞培养上清液及乳腺癌患者血清中的可溶性肿瘤坏死因子受体(sTNF-Rs)。检测在包括手术和化疗的治疗前后进行。在未经任何治疗的患者中性粒细胞培养上清液中观察到sTNFRp55和sTNFRp75的最高浓度,治疗后中性粒细胞培养上清液中它们的浓度较低。乳腺癌患者血清中sTNFRp55和sTNFRp75水平升高。手术治疗导致sTNFRp55和sTNFRp75浓度更高。辅助化疗后患者血清中sTNF-Rs水平降低。中性粒细胞释放TNF调节蛋白——sTNF-Rs的不同能力似乎证实了中性粒细胞在恶性过程中通过sTNF-Rs释放参与宿主TNF介导的反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验